Matthew M. Zhao - Concepedia

Author

Matthew M. Zhao

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

M. ZHAO, Matthew M. Zhao, Matthew Zhao

Publications

880

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Lexicon Pharmaceuticals (United States)

About

Matthew M. Zhao is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	316
2	Natural Sciences	6	6	297
3	Biochemistry	5	5	277
4	Engineering	3	3	298
5	Allergy	1	1	17

Matthew M. Zhao

Publications

632

Citations

H-Index

Page 1

	Year	Citations
Pd‐Catalyzed N‐Arylation of Heteroarylamines. Jingjun Yin, Matthew M. Zhao, Mark A. Huffman, ChemInform Cross-coupling ReactionAbstract AlgebraEngineeringAbstraction (Computer Science)Organic Chemistry	2003	171
Efficient Synthesis of NK<sub>1</sub> Receptor Antagonist Aprepitant Using a Crystallization-Induced Diastereoselective Transformation Karel M. J. Brands, Joseph F. Payack, Jonathan D. Rosen, Journal of the American Chemical Society Medicinal ChemistryBiochemistryFunctional SelectivityLewis AcidReceptor Antagonist Aprepitant	2003	156
Direct and Convenient Conversion of Alcohols to Fluorides Jingjun Yin, Devin S. Zarkowsky, David W. Thomas, Organic Letters Chemical TechnologyCombinatorial ChemistryEngineeringHighest ReactivityFluorous Synthesis	2004	101
Practical Asymmetric Synthesis of Aprepitant, a Potent Human NK-1 Receptor Antagonist, via a Stereoselective Lewis Acid-Catalyzed Trans Acetalization Reaction Matthew M. Zhao, James M. McNamara, Guo-Jie Ho, The Journal of Organic Chemistry Medicinal ChemistryBioorganic ChemistryBiochemistryNatural SciencesMedicine	2002	65
Zn/CuI-Mediated Coupling of Alkyl Halides with Vinyl Sulfones, Vinyl Sulfonates, and Vinyl Sulfonamides Matthew M. Zhao, Chuanxing Qu, Joseph E. Lynch The Journal of Organic Chemistry Chemical EngineeringCross-coupling ReactionEngineeringNovel OrganocatalystsSuperior Solvent	2005	26
Process Development of Sotagliflozin, a Dual Inhibitor of Sodium–Glucose Cotransporter-1/2 for the Treatment of Diabetes Matthew M. Zhao, Haiming Zhang, Shinya Iimura, Organic Process Research & Development Dual InhibitorBioorganic ChemistrySodium–glucose Cotransporter-1/2Contiguous Chiral CentersGlycobiology	2020	21
Efficient Synthesis of a Highly Selective NPY-5 Receptor Antagonist: A Drug Candidate for the Treatment of Obesity Takahiro Itoh, Shinji Kato, Nobuaki Nonoyama, Organic Process Research & Development PharmacotherapyEfficient SynthesisPharmaceutical ChemistryObesityDiversity Oriented Synthesis	2006	20
Asymmetric synthesis of a selective endothelin A receptor antagonist Yoshiaki Kato, Kenji Niiyama, Takayuki Nemoto, Tetrahedron Functional SelectivityMedicineAsymmetric SynthesisReceptor (Biochemistry)Pharmacological Agent	2002	19
A very concise synthesis of a potent N-(1,3-thiazol-2-yl)pyridin-2-amine KDR kinase inhibitor Matthew M. Zhao, Jingjun Yin, Mark A. Huffman, Tetrahedron Combinatorial ChemistryConcise SynthesisMedicinal ChemistryBiochemistryPotent N-	2005	18
Reductive decyanation of pyrazinecarbonitriles Jennifer Albaneze‐Walker, Matthew M. Zhao, Melinda D. Baker, Tetrahedron Letters Organic ChemistryReductive DecyanationStereoselective SynthesisChemistry	2002	18

Page 1